Relmada Therapeutics, Inc.
RLMD
Revenue
682.00
▼-1.17k▼-63.14%
3 Months ChangeAssets
71.03M
▼-13.38M▼-15.85%
3 Months ChangeLiabilities
12.36M
▲167.03k▲1.37%
3 Months ChangeFree Cash Flow
-981.64k
▲1.19M▲54.75%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-07
Form 10-Q
ID: 0001213900-24-066111
2024-05-30
Form 8-K
ID: 0001213900-24-047968
2024-05-08
Form 10-Q
ID: 0001213900-24-040856
2024-03-19
Form 8-K
ID: 0001213900-24-024022
2024-01-11
Form 8-K
ID: 0001213900-24-003000
2024-01-04
Form 8-K
ID: 0001213900-24-000999
2024-01-03
Form 8-K
ID: 0001213900-24-000858
2023-11-08
Form 10-Q
ID: 0001213900-23-084737
2023-11-08
Form 8-K
ID: 0001213900-23-084735
2023-10-11
Form 8-K
ID: 0001013762-23-002985